EZZ Life Science Holdings (ASX:EZZ) Cash, Cash Equivalents, Marketable Securities : A$12.62 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings Cash, Cash Equivalents, Marketable Securities?

EZZ Life Science Holdings's quarterly cash, cash equivalents, marketable securities increased from Dec. 2022 (A$9.59 Mil) to Jun. 2023 (A$13.83 Mil) but then stayed the same from Jun. 2023 (A$13.83 Mil) to Dec. 2023 (A$12.62 Mil).

EZZ Life Science Holdings's annual cash, cash equivalents, marketable securities increased from Jun. 2021 (A$8.85 Mil) to Jun. 2022 (A$10.47 Mil) and increased from Jun. 2022 (A$10.47 Mil) to Jun. 2023 (A$13.83 Mil).

EZZ Life Science Holdings Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for EZZ Life Science Holdings's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings Cash, Cash Equivalents, Marketable Securities Chart

EZZ Life Science Holdings Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Cash, Cash Equivalents, Marketable Securities

8.41

8.85

10.47

13.83

EZZ Life Science Holdings Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial			8.95	10.47	9.59	13.83	12.62

EZZ Life Science Holdings Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

EZZ Life Science Holdings (ASX:EZZ) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

EZZ Life Science Holdings Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

EZZ Life Science Holdings (ASX:EZZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

104 Derby Street, Silverwater, NSW, AUS, 2128

Website

https://www.ezzlife.com.au

EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines